Evidence map›Paper›PMID 28073314›Full record

ArticleJournal of intensive care medicine2019

Safety of the Peripheral Administration of Vasopressor Agents.

Tyler Lewis, Cristian Merchan, Diana Altshuler, John Papadopoulos

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of intensive care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Observational
  9. Review
  10. Review
  11. Article
  12. Article
  13. Overview of Peripheral Vasopressor Use in an Academic Health System.Annals of the American Thoracic Society · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Ten key statements on the guideline "Peripheral administration of vasopressors"].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tyler Lewis1 Department of Pharmacy, NYU Langone Medical Center, New York, NY, USA.
Cristian Merchan1 Department of Pharmacy, NYU Langone Medical Center, New York, NY, USA.
Diana Altshuler1 Department of Pharmacy, NYU Langone Medical Center, New York, NY, USA.
John Papadopoulos1 Department of Pharmacy, NYU Langone Medical Center, New York, NY, USA.
NYU Langone Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasopressors are an integral component of the management of septic shock and are traditionally given via a central venous catheter (CVC) due to the risk of tissue injury and necrosis if extravasated. However, the need for a CVC for the management of septic shock has been questioned, and the risk of extravasation and incidence of severe injury when vasopressors are given via a peripheral venous line (PVL) remains poorly defined. We performed a retrospective chart review of 202 patients who received vasopressors through a PVL. The objective was to describe the vasopressors administered peripherally, PVL size and location, the incidence of extravasation events, and the management of extravasation events. The primary vasopressors used were norepinephrine and phenylephrine. The most common PVL sites used were the forearm and antecubital fossa. The incidence of extravasation was 4%. All of the events were managed conservatively; none required an antidote or surgical management. Vasopressors were restarted at another peripheral site in 88% of the events. The incidence of extravasation was similar to prior studies. The use of a PVL for administration of vasopressors can be considered in patients with a contraindication to a CVC.

Indexed as

Catheterization, PeripheralCritical CareInfusions, IntravenousAgedAged, 80 and overFemaleHemodynamicsHumansMaleRandomized Controlled Trials as TopicRetrospective StudiesShock, SepticTreatment OutcomeVasoconstrictor AgentsVasoconstrictor Agentscentral venous catheterextravasationperipheral venous linesafetyseptic shockvasopressors

Identifiers

PMID28073314
OpenAlexW2574261120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.